Skip to main content
. 2017 Nov 2;16:141. doi: 10.1186/s12933-017-0624-5

Fig. 4.

Fig. 4

Clots from three type 2 diabetes individuals with added amyloid–specific fluorescent markers (rows a to c represent 3 different individuals with type 2 diabetes); columns from left to right Amytracker 680 (red), Amytracker 480 (blue) and ThT (green)